Holen Sie sich die Stockscreener-App
18.00
6.10%
1.035
Schlusskurs vom Vortag:
$16.97
Offen:
$16.91
24-Stunden-Volumen:
366.63K
Relative Volume:
0.94
Marktkapitalisierung:
$326.50M
Einnahmen:
$1.93M
Nettoeinkommen (Verlust:
$-7.96M
KGV:
-0.0051
EPS:
-3530.8178
Netto-Cashflow:
$-36.78M
1W Leistung:
-2.94%
1M Leistung:
+11.90%
6M Leistung:
+313.91%
1J Leistung:
+80.05%
1-Tages-Spanne:
$16.63
$18.80
1-Wochen-Bereich:
$15.53
$19.25
52-Wochen-Spanne:
$3.39
$19.41
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Firmenname
Avalo Therapeutics Inc
Sektor
Branche
Telefon
410-522-8707
Adresse
1500 LIBERTY RIDGE DRIVE, WAYNE
Vergleichen Sie AVTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
18.00 | 307.73M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Bestätigt | H.C. Wainwright | Buy |
| 2025-09-05 | Eingeleitet | TD Cowen | Buy |
| 2025-08-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-25 | Eingeleitet | Jefferies | Buy |
| 2025-03-25 | Eingeleitet | Stifel | Buy |
| 2025-02-28 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-21 | Eingeleitet | Wedbush | Outperform |
| 2024-12-19 | Eingeleitet | BTIG Research | Buy |
| 2024-10-24 | Eingeleitet | H.C. Wainwright | Neutral |
| 2024-04-16 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-09-24 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Avalo Therapeutics Inc Aktie (AVTX) Neueste Nachrichten
Why analysts maintain buy rating on Avalo Therapeutics Inc. (C6K0) stockStop Loss & Stock Portfolio Risk Control - Newser
Why Avalo Therapeutics Inc. (C6K0) stock could be next leaderOil Prices & Community Supported Trade Ideas - Newser
Why Avalo Therapeutics Inc. (C6K0) stock stays resilient2025 Support & Resistance & Risk Managed Investment Strategies - Newser
How buybacks impact Avalo Therapeutics Inc. stock value2025 Winners & Losers & Low Risk Investment Opportunities - Newser
What hedge fund activity signals for Avalo Therapeutics Inc. stockDip Buying & Low Drawdown Trading Techniques - Newser
Financial Comparison: InMed Pharmaceuticals (NASDAQ:INM) & Avalo Therapeutics (NASDAQ:AVTX) - Defense World
Is Avalo Therapeutics Inc. (C6K0) stock a top dividend aristocrat candidateNew Guidance & Safe Entry Momentum Tips - Newser
Published on: 2025-12-03 02:49:42 - Newser
Is Avalo Therapeutics Inc. (C6K0) stock overpriced at current multiplesWeekly Market Summary & Low Drawdown Investment Ideas - Newser
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives $31.67 Average PT from Analysts - Defense World
Taking the lead: Avalo Therapeutics Inc (AVTX) - Setenews
How Avalo Therapeutics Inc. stock benefits from strong dollarTrade Exit Summary & AI Based Buy and Sell Signals - Newser
Avalo Therapeutics, Inc. Updates Investor Presentation - TradingView
Is Avalo Therapeutics Inc. (C6K0) stock resilient in recession scenariosWeekly Risk Summary & Smart Allocation Stock Reports - Newser
What is the fair value of Avalo Therapeutics Inc. stock nowInflation Watch & Risk Controlled Stock Pick Alerts - Newser
How Avalo Therapeutics Inc. (C6K0) stock performs in easing cyclesGap Up & Community Consensus Trade Alerts - Newser
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Avalo Therapeutics Reports Q3 2025 Financial Results - MSN
HC Wainwright Has Bearish Estimate for AVTX FY2025 Earnings - Defense World
How Avalo Therapeutics Inc. (C6K0) stock stacks up against competitorsJuly 2025 Spike Watch & Risk Controlled Daily Trade Plans - newser.com
What valuation ratios show for Avalo Therapeutics Inc. (C6K0) stockRate Hike & Fast Momentum Stock Entry Tips - newser.com
How Avalo Therapeutics Inc. (C6K0) stock valuation compares with sectorMarket Activity Recap & Weekly Momentum Picks - newser.com
Is Avalo Therapeutics Inc. stock supported by strong cash flowsMarket Performance Recap & Smart Swing Trading Alerts - newser.com
Has Avalo Therapeutics Inc. formed a bullish divergenceJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com
D pipelineJuly 2025 Market Mood & Technical Pattern Recognition Alerts - newser.com
Avalo Therapeutics, Inc. (AVTX) -3.17% in Pre-market: Stock Slides Amid Recent Developments - Stocks Telegraph
Can Avalo Therapeutics Inc. (C6K0) stock test all time highsChart Signals & Comprehensive Market Scan Reports - newser.com
Finanzdaten der Avalo Therapeutics Inc-Aktie (AVTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):